TY  - JOUR

T1  - OpenSAFELY: The impact of COVID‐19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate

JO  - British Journal of Clinical Pharmacology

UR  - https://eprints.whiterose.ac.uk/id/eprint/211397

PY  - 2024/04/08

AU  - Brown AD

AU  - Fisher L

AU  - Curtis HJ

AU  - Wiedemann M

AU  - Hulme WJ

AU  - Speed V

AU  - Hopcroft LEM

AU  - Cunningham C

AU  - Costello RE

AU  - Galloway JB

AU  - Russell MD et al

ED  - 

DO  - DOI: 10.1111/bcp.16062

PB  - Wiley

Y2  - 2025/04/06

ER  -